Interim Results of Outpatient Levodopa-Carbidopa Intestinal Gel Titration in Advanced Parkinson's Disease

被引：0
|
作者：
Rodriguez, Ramon
Lobatz, Michael
Dubow, Jordan
Eaton, Susan
Hall, Coleen
Chatamra, Krai
Benesh, Janet A.
机构：
来源：
ANNALS OF NEUROLOGY | 2015年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S444
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [21] Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson's disease patients
    Karadag, Yesim Sucullu
    Saltoglu, Tugce
    Kucukdagli, Fadime Erdogan
    Ozturk, Omer
    Koseoglu, Tankut
    Altiparmak, Emin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (01) : 84 - 89
  • [22] Effect of levodopa-carbidopa intestinal gel on resting tremor in patients with advanced Parkinson's disease
    Fernandez, H. H.
    Dubow, J.
    Robieson, W. Z.
    Chatamra, K.
    Eaton, S.
    Benesh, J. A.
    Odin, P.
    MOVEMENT DISORDERS, 2015, 30 : S84 - S85
  • [23] Long-Term Safety of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
    Rodriguez, Ramon L.
    Schmulewitz, Nathan
    Hall, Coleen
    Eaton, Susan
    Dubow, Jordan
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2014, 76 : S46 - S46
  • [24] Effect of Levodopa-Carbidopa Intestinal Gel on Resting Tremor in Patients with Advanced Parkinson's Disease
    Fernandez, Hubert
    Dubow, Jordan
    Robieson, Weining
    Chatamra, Krai
    Eaton, Susan
    Benesh, Janet
    Odin, Per
    NEUROLOGY, 2016, 86
  • [25] Efficacy of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Subgroup analyses
    Standaert, D. G.
    Slevin, J. T.
    Espay, A. J.
    Boyd, J. T.
    Fernandez, H. H.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S144
  • [26] Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson’s disease
    Fernandez H.H.
    Robieson W.Z.
    Chatamra K.
    Dubow J.
    Eaton S.
    Benesh J.A.
    Odin P.
    npj Parkinson's Disease, 2 (1)
  • [27] The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson's Disease: A Systematic Review
    Zhang, Xing-Ru
    Jiang, Zhi-Yu
    Zhang, Zeng-Rui
    Chen, Hui-Jun
    Wu, Ke
    He, Jin-Cai
    Xie, Cheng-Long
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 845 - 854
  • [28] The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England
    Chaudhuri, K. Ray
    Pickard, A. Simon
    Alobaidi, Ali
    Jalundhwala, Yash J.
    Kandukuri, Prasanna L.
    Bao, Yanjun
    Sus, Julia
    Jones, Glynn
    Ridley, Christian
    Oddsdottir, Julia
    Najle-Rahim, Seyavash
    Madin-Warburton, Matthew
    Xu, Weiwei
    Schrag, Anette
    PHARMACOECONOMICS, 2022, 40 (05) : 559 - 574
  • [29] Effect of age on efficacy and safety of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: interim analysis of the DUOGLOBE study
    Aldred, J.
    Chaudhari, R. K.
    Siddiqui, M.
    Bergmann, L.
    Robieson, W.
    Kukreja, P.
    Kovacs, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 452 - 452
  • [30] Efficacy and safety of Levodopa-Carbidopa Intestinal Gel in the treatment of Parkinson's Disease
    Londero, E.
    dos Santos, A. P.
    Braga, R.
    de Barros, R.
    dos Reis, L.
    Freire, G.
    MOVEMENT DISORDERS, 2021, 36 : S220 - S220
12345